LabCorp Tells Albright Not To Triple $272M IP Judgment

By Jasmin Boyce · October 20, 2022, 4:06 PM EDT

LabCorp has urged U.S. District Judge Alan Albright not to enhance a $272 million jury verdict against it in a biotechnology company's patent suit over a testing method for genetic disorders,...

To view the full article, register now.

Documents

Case Information

Case Title

Ravgen, Inc. v. Laboratory Corporation of America Holdings

Case Number

6:20-cv-00969

Court

Texas Western

Nature of Suit

Patent

Date Filed

October 16, 2020